DalsnaFinance

Aktis Oncology Inc $AKTS

Health Care

Russell 2000 Massachusetts
Create a scorecard
$16.76
+0.34 (+2.07%)
As of Oct 22, 2026, 9:32 PM EDT
Price history
Loading chart…

Aktis Oncology Inc (AKTS) is trading up at $16.76 (+2.07%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: January 9, 2026 · $18.00 offering · NASDAQ · View IPO details →

Aktis Oncology Inc revenue & net income history

RevenueNet incomeNet margin (right axis, %)
$3.38M−$10.4M−$24.1MQ1 FY2025 revenue: $1.45MQ1 FY2025 net income: −$15.0M · Net margin −1035.6%Q1 '25Q2 FY2025 revenue: $1.60MQ2 FY2025 net income: −$18.1M · Net margin −1129.0%Q2 '25Q1 FY2026 revenue: $3.23MQ1 FY2026 net income: −$18.3M · Net margin −567.9%Q1 '26Q2 FY2026 revenue: $3.38MQ2 FY2026 net income: −$24.1M · Net margin −713.5%Q2 '26−100%−75%−50%−25%0%Q1 FY2025 net margin: −1035.6% (off the scale, which stops at −100.0%)Q2 FY2025 net margin: −1129.0% (off the scale, which stops at −100.0%)Q1 FY2026 net margin: −567.9% (off the scale, which stops at −100.0%)Q2 FY2026 net margin: −713.5% (off the scale, which stops at −100.0%)
Aktis Oncology Inc quarterly financial statements
Q1 FY25Mar 2025Q2 FY25Jun 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Income statement
Revenue$1.45M$1.60M$3.23M$3.38M
Growth (year over year)——+123.0%+111.4%
Operating income−$18.1M−$21.0M−$22.7M−$28.9M
Operating margin−1253.8%−1309.4%−703.6%−854.0%
Net income−$15.0M−$18.1M−$18.3M−$24.1M
Net margin−1035.6%−1129.0%−567.9%−713.5%
EPS (diluted)−$18.60−$22.39−$0.38−$0.44
Balance sheet
Cash and equivalents$58.3M$110.2M$371.6M$82.5M
Total assets——$576.8M$557.6M
Total liabilities——$70.7M$72.8M
Shareholders' equity−$101.6M−$118.2M$506.1M$484.8M
Cash flow
Operating cash flow−$17.5M−$16.2M−$24.2M−$20.6M
Capital expenditure$1.89M$1.53M$1.85M$1.26M
Free cash flow−$19.4M−$17.7M−$26.1M−$21.8M

From Aktis Oncology Inc's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. Filings on SEC EDGAR →

About Aktis Oncology Inc

Headquarters
Boston, Massachusetts From SEC filings, Oct 2026

Recent News (1)

More Health Care stocks

Browse all companies →